Pathologic Myopia
📧 Sign up to get email alerts when something new happens for Pathologic Myopia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-02-21Clinical Trial Update: A Prospective, Randomized Clinical Study of Two Phakic Toric Implantable Lenses [NA]
A prospective randomized clinical trial comparing two phakic toric intraocular lenses for myopia with astigmatism is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2017-07-28Clinical Trial Update: Ocular Discomfort Assessment After Intravitreal Injections [NA]
This completed clinical trial update reports measurements of ocular discomfort after intravitreal injections. The findings may inform the sa…
-
CLINICAL_TRIALS trial_result · 2014-04-01Clinical Trial Update: VEGF Trap-Eye in Choroidal Neovascularization Secondary to Pathologic Myopia (mCNV) [Phase 3]
Phase 3 trial evaluating VEGF Trap-Eye for choroidal neovascularization due to pathologic myopia has completed, with results posted in 2014.…
-
CLINICAL_TRIALS trial_result · 2013-10-28Clinical Trial Update: Reduced-fluence Verteporfin Photodynamic Therapy Plus Ranibizumab for Choroidal Neovascularization in Pathologic Myopia [Phase 1]
Phase 1 trial evaluating reduced-fluence verteporfin photodynamic therapy in combination with ranibizumab for choroidal neovascularization i…
-
CLINICAL_TRIALS trial_result · 2011-11-01Clinical Trial Update: Safety and Efficacy Study of Combretastatin A4 Phosphate to Treat Patients With Choroidal Neovascularization Secondary to Pathologic Myopia [Phase 2]
Phase 2 trial assessing safety and efficacy of Combretastatin A4 Phosphate for choroidal neovascularization secondary to pathologic myopia h…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.